RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AFT Pharmaceuticals Stock

AFT Pharmaceuticals Net Income 2024

AFT Pharmaceuticals Net Income

15.61 M NZD

Ticker

AFT.NZ

ISIN

NZAFTE0001S4

WKN

A2DVUC

In 2024, AFT Pharmaceuticals's profit amounted to 15.61 M NZD, a 46.51% increase from the 10.65 M NZD profit recorded in the previous year.

The AFT Pharmaceuticals Net Income history

YEARNET INCOME (undefined NZD)
2027e28.86
2026e25.38
2025e17.16
202415.61
202310.65
202219.85
20217.59
202011.7
2019-3.36
2018-13.62
2017-18.39
2016-13.27
2015-12.87
2014-1.11
20130.17
20120.9

AFT Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into AFT Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AFT Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AFT Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of AFT Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into AFT Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing AFT Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AFT Pharmaceuticals’s growth potential.

AFT Pharmaceuticals Revenue, EBIT and net profit per share

DateAFT Pharmaceuticals RevenueAFT Pharmaceuticals EBITAFT Pharmaceuticals Net Income
2027e287.84 M undefined46.07 M undefined28.86 M undefined
2026e261.27 M undefined36.82 M undefined25.38 M undefined
2025e225.81 M undefined25.46 M undefined17.16 M undefined
2024195.41 M undefined24.24 M undefined15.61 M undefined
2023156.64 M undefined19.67 M undefined10.65 M undefined
2022130.31 M undefined20.39 M undefined19.85 M undefined
2021113.11 M undefined10.71 M undefined7.59 M undefined
2020105.6 M undefined11.5 M undefined11.7 M undefined
201985.13 M undefined6.64 M undefined-3.36 M undefined
201881.18 M undefined-8.65 M undefined-13.62 M undefined
201769.21 M undefined-14.39 M undefined-18.39 M undefined
201664.01 M undefined-8.66 M undefined-13.27 M undefined
201556.24 M undefined-5.97 M undefined-12.87 M undefined
201448.94 M undefined860,000 undefined-1.11 M undefined
201340.36 M undefined1.09 M undefined170,000 undefined
201234.74 M undefined1.95 M undefined900,000 undefined

AFT Pharmaceuticals stock margins

The AFT Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AFT Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AFT Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the AFT Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the AFT Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the AFT Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the AFT Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AFT Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AFT Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AFT Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

AFT Pharmaceuticals Margin History

AFT Pharmaceuticals Gross marginAFT Pharmaceuticals Profit marginAFT Pharmaceuticals EBIT marginAFT Pharmaceuticals Profit margin
2027e45.17 %16.01 %10.03 %
2026e45.17 %14.09 %9.72 %
2025e45.17 %11.27 %7.6 %
202445.17 %12.4 %7.99 %
202346.59 %12.56 %6.8 %
202247.4 %15.65 %15.23 %
202143.09 %9.47 %6.71 %
202045.71 %10.89 %11.08 %
201947.85 %7.8 %-3.95 %
201843.48 %-10.65 %-16.78 %
201737.57 %-20.79 %-26.57 %
201636.83 %-13.52 %-20.73 %
201537.62 %-10.61 %-22.89 %
201441.54 %1.76 %-2.27 %
201343.71 %2.7 %0.42 %
201244.21 %5.61 %2.59 %

AFT Pharmaceuticals Aktienanalyse

What does AFT Pharmaceuticals do?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding AFT Pharmaceuticals's Profit Margins

The profit margins of AFT Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of AFT Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating AFT Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

AFT Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When AFT Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about AFT Pharmaceuticals stock

How much profit has AFT Pharmaceuticals made this year?

AFT Pharmaceuticals has made 15.61 M NZD this year.

How has the profit developed compared to last year?

The profit has increased by 46.51% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does AFT Pharmaceuticals publish its earnings?

AFT Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of AFT Pharmaceuticals?

The profits of AFT Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of AFT Pharmaceuticals?

You can learn more about the earnings of AFT Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does AFT Pharmaceuticals pay?

Over the past 12 months, AFT Pharmaceuticals paid a dividend of 0.02 NZD . This corresponds to a dividend yield of about 0.48 %. For the coming 12 months, AFT Pharmaceuticals is expected to pay a dividend of 0.02 NZD.

What is the dividend yield of AFT Pharmaceuticals?

The current dividend yield of AFT Pharmaceuticals is 0.48 %.

When does AFT Pharmaceuticals pay dividends?

AFT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AFT Pharmaceuticals?

AFT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of AFT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0.02 NZD are expected. This corresponds to a dividend yield of 0.48 %.

In which sector is AFT Pharmaceuticals located?

AFT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFT Pharmaceuticals from 7/4/2024 amounting to 0.016 NZD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did AFT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of AFT Pharmaceuticals in the year 2023?

In the year 2023, AFT Pharmaceuticals distributed 0.011 NZD as dividends.

In which currency does AFT Pharmaceuticals pay out the dividend?

The dividends of AFT Pharmaceuticals are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AFT Pharmaceuticals

Our stock analysis for AFT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AFT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.